Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Number of holders
-
459
-
Total 13F shares, excl. options
-
179,234,022
-
Shares change
-
-2,085,315
-
Total reported value, excl. options
-
$15,261,762,453
-
Value change
-
-$186,785,701
-
Put/Call ratio
-
66.21%
-
Number of buys
-
183
-
Number of sells
-
-230
-
Price
-
$85.15
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q4 2018
548 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q4 2018.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 459 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 179,234,022 shares
of 193,539,047 outstanding shares and own 92.61% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (18,304,163 shares), Vanguard Group Inc (15,541,904 shares), PRIMECAP MANAGEMENT CO/CA/ (14,185,173 shares), BlackRock Inc. (13,578,562 shares), JENNISON ASSOCIATES LLC (11,600,460 shares), BAKER BROS. ADVISORS LP (7,589,294 shares), SANDS CAPITAL MANAGEMENT, LLC (6,107,460 shares), Viking Global Investors LP (5,091,637 shares), Clearbridge Investments, LLC (4,505,662 shares), and STATE STREET CORP (3,897,563 shares).
This table shows the top 459 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.